Accuray Press Releases
The most recent Accuray press releases, highlighting news about our company and our radiation therapy technologies.
- Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
More than 40 Clinical Studies Using Accuray Technology Presented at ESTRO 2025; Company Highlights Innovation and Educational Symposia MADISON, Wis. , May 7, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and
- Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System
Medical Team's Use of Accuray CyberComm™ Reduced Commissioning Time by Approximately 50 Percent*, Enabling Them to Initiate Patient Treatments Sooner MADISON, Wis. , May 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CyberKnife ® Center Salzburg is the […]
- Accuray Reports Fiscal 2025 Third Quarter Financial Results
MADISON, Wis. , April 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2025 . Key Fiscal Third Quarter Highlights: Total net revenue was $113.2 million , an increase of 12 percent year-over-year Net loss was […]
- Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025
MADISON, Wis. , April 16, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2025, ended March 31, 2025 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on April 30, 2025 .
- Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting
Data Also Highlights Continued Clinical Advances Using the CyberKnife System That are Making High Quality Care an Option for People Who Previously Had Limited Choices MADISON, Wis. , April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use
